Erysipelas and lymphedema
Identifieur interne : 000483 ( France/Analysis ); précédent : 000482; suivant : 000484Erysipelas and lymphedema
Auteurs : Loïc Vaillant [France]Source :
- Phlebolymphology [ 1286-0107 ] ; 2007.
Descripteurs français
- Pascal (Inist)
- Wicri :
- topic : Enfant, Antibiotique.
English descriptors
- KwdEn :
Abstract
Erysipelas is a nonnecrotizing bacterial hypodermal cellulitis usually associated with streptococcal infection. It may be a mainly secondary complication of chronic lymphedema, and occurs in 20% to 30% of cases. The first presenting signs are sudden fever and shivering. The clinical feature is inflammatory plaque, which is often chronic and accompanied by fever. Inflammatory plaque is promoted by lymph stasis, and is marked by inflammatory episodes that often regress spontaneously. Erysipelas per se is mainly treated with antibiotics, and adjuvant therapies are not justified. The prevention of recurrence is primary. Since lymphedema is the first risk factor for recurrence, its treatment and risk of occurrence must be considered. This includes physiotherapy, well-adapted compression therapy, and avoidance of wounds.
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream PascalFrancis, to step Corpus: 000423
- to stream PascalFrancis, to step Curation: 000537
- to stream PascalFrancis, to step Checkpoint: 000475
- to stream Main, to step Merge: 007919
- to stream Main, to step Curation: 007755
- to stream Main, to step Exploration: 007755
- to stream France, to step Extraction: 000483
Links to Exploration step
Pascal:08-0028056Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en" level="a">Erysipelas and lymphedema</title>
<author><name sortKey="Vaillant, Loic" sort="Vaillant, Loic" uniqKey="Vaillant L" first="Loïc" last="Vaillant">Loïc Vaillant</name>
<affiliation wicri:level="3"><inist:fA14 i1="01"><s1>Université François Rabelais</s1>
<s2>Tours</s2>
<s3>FRA</s3>
<sZ>1 aut.</sZ>
</inist:fA14>
<country>France</country>
<placeName><region type="region">Centre-Val de Loire</region>
<region type="old region">Région Centre</region>
<settlement type="city">Tours</settlement>
</placeName>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">INIST</idno>
<idno type="inist">08-0028056</idno>
<date when="2007">2007</date>
<idno type="stanalyst">PASCAL 08-0028056 INIST</idno>
<idno type="RBID">Pascal:08-0028056</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">000423</idno>
<idno type="wicri:Area/PascalFrancis/Curation">000537</idno>
<idno type="wicri:Area/PascalFrancis/Checkpoint">000475</idno>
<idno type="wicri:explorRef" wicri:stream="PascalFrancis" wicri:step="Checkpoint">000475</idno>
<idno type="wicri:doubleKey">1286-0107:2007:Vaillant L:erysipelas:and:lymphedema</idno>
<idno type="wicri:Area/Main/Merge">007919</idno>
<idno type="wicri:Area/Main/Curation">007755</idno>
<idno type="wicri:Area/Main/Exploration">007755</idno>
<idno type="wicri:Area/France/Extraction">000483</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en" level="a">Erysipelas and lymphedema</title>
<author><name sortKey="Vaillant, Loic" sort="Vaillant, Loic" uniqKey="Vaillant L" first="Loïc" last="Vaillant">Loïc Vaillant</name>
<affiliation wicri:level="3"><inist:fA14 i1="01"><s1>Université François Rabelais</s1>
<s2>Tours</s2>
<s3>FRA</s3>
<sZ>1 aut.</sZ>
</inist:fA14>
<country>France</country>
<placeName><region type="region">Centre-Val de Loire</region>
<region type="old region">Région Centre</region>
<settlement type="city">Tours</settlement>
</placeName>
</affiliation>
</author>
</analytic>
<series><title level="j" type="main">Phlebolymphology</title>
<idno type="ISSN">1286-0107</idno>
<imprint><date when="2007">2007</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt><title level="j" type="main">Phlebolymphology</title>
<idno type="ISSN">1286-0107</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Acquired</term>
<term>Antibiotic</term>
<term>Bacteriosis</term>
<term>Cellulitis</term>
<term>Child</term>
<term>Chronic</term>
<term>Complication</term>
<term>Congenital</term>
<term>Diosmin</term>
<term>Erysipelas</term>
<term>Fever</term>
<term>Genetic disease</term>
<term>Lymph</term>
<term>Lymphatic circulation</term>
<term>Lymphedema</term>
<term>Mammary gland</term>
<term>Physiotherapy</term>
<term>Prevention</term>
<term>Risk factor</term>
<term>Streptococcal infection</term>
<term>Treatment</term>
<term>Venotropic agent</term>
<term>Wound</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr"><term>Cellulite</term>
<term>Lymphoedème</term>
<term>Maladie héréditaire</term>
<term>Bactériose</term>
<term>Streptococcie</term>
<term>Erysipèle</term>
<term>Acquis</term>
<term>Congénital</term>
<term>Enfant</term>
<term>Diosmine</term>
<term>Glande mammaire</term>
<term>Circulation lymphatique</term>
<term>Complication</term>
<term>Chronique</term>
<term>Fièvre</term>
<term>Lymphe</term>
<term>Traitement</term>
<term>Antibiotique</term>
<term>Prévention</term>
<term>Facteur risque</term>
<term>Physiothérapie</term>
<term>Plaie</term>
<term>Veinotrope</term>
</keywords>
<keywords scheme="Wicri" type="topic" xml:lang="fr"><term>Enfant</term>
<term>Antibiotique</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Erysipelas is a nonnecrotizing bacterial hypodermal cellulitis usually associated with streptococcal infection. It may be a mainly secondary complication of chronic lymphedema, and occurs in 20% to 30% of cases. The first presenting signs are sudden fever and shivering. The clinical feature is inflammatory plaque, which is often chronic and accompanied by fever. Inflammatory plaque is promoted by lymph stasis, and is marked by inflammatory episodes that often regress spontaneously. Erysipelas per se is mainly treated with antibiotics, and adjuvant therapies are not justified. The prevention of recurrence is primary. Since lymphedema is the first risk factor for recurrence, its treatment and risk of occurrence must be considered. This includes physiotherapy, well-adapted compression therapy, and avoidance of wounds.</div>
</front>
</TEI>
<affiliations><list><country><li>France</li>
</country>
<region><li>Centre-Val de Loire</li>
<li>Région Centre</li>
</region>
<settlement><li>Tours</li>
</settlement>
</list>
<tree><country name="France"><region name="Centre-Val de Loire"><name sortKey="Vaillant, Loic" sort="Vaillant, Loic" uniqKey="Vaillant L" first="Loïc" last="Vaillant">Loïc Vaillant</name>
</region>
</country>
</tree>
</affiliations>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/France/Analysis
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000483 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/France/Analysis/biblio.hfd -nk 000483 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Sante |area= LymphedemaV1 |flux= France |étape= Analysis |type= RBID |clé= Pascal:08-0028056 |texte= Erysipelas and lymphedema }}
This area was generated with Dilib version V0.6.31. |